||COM SHS NPV (DI)
||EPS - Basic
||Market Cap (m)
Dalradian Cmn Share Discussion Threads
Showing 1 to 10 of 25 messages
Chat Pages: 1
|Not bad to raise C$7m through some warrants !|
|Anyone watching here?What's the thinking?|
|Am keeping an eye on this one....
Thanks for the research notes above....|
|No dilution, it will be financed with debt and cash. Its a low cost mine in the scheme of things with exceptionally high ore grades.
I f you want a really cheap entry to this play have a look at Minco|
|Why invest when so far away from production with lots more dilution to come? Maybe in 2017-2018|
|Very surprised more investors aren'y on to this one yet. Obviously nobody wants goodies at the moment but with so many brokers issuing strong buy recommendations it certainly looks like one to put away now for a healthy return in a couple of years time.|
|Shares of Dalradian Resources (TSE:DNA) have been given a consensus rating of “Buy” by the six brokerages that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is C$1.22.
|Dalradian Resources (TSE:DNA) will issue its quarterly earnings data on Wednesday, August 12th. Analysts expect the company to announce earnings of ($0.01) per share for the quarter.
“DNA currently trades at $29/oz, or ~25% of PRB’s takeout value,” the note states.
|still cheap it would seem (compared to peer company Probe)
The note goes on to assert that there are “a limited number of high-quality projects available,” meaning that producers with healthy balance sheets will be closely keeping an eye on undervalued developers such as Dalradian. “We submit that Dalradian, owns one of these high-quality assets as Curraghinalt offers palatable capex and high grades which result in strong project economics in a reasonable jurisdiction,” the firm states.
Furthermore, the firm argues that Dalradian has a relatively discounted valuation compared to Probe, comparing the two companies on the basis that both focus on higher-grade, underground deposits. “DNA currently trades at $29/oz, or ~25% of PRB’s takeout value,” the note states. It also points out that a preliminary economic assessment has been completed for Curraghinalt, while Probe’s project has not yet reached that stage.
Chat Pages: 1